Loading
NASDAQHealthcareMedical - Devices
Latest quote
$8.14
+$0.135 · +1.69%
Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients. Another notable offering is the TearCare System, a wearable eyelid technology employed by ophthalmologists and optometrists for managing dry eye disease (DED). The company makes its products available across the United States, reaching hospitals, medical centers, and eye care professionals through its direct sales force and distribution partners. Founded in 2010, Sight Sciences' corporate operations are based in Menlo Park, California.
Previous close
$8.14
+$0.135 · +1.69%
Regular session · ET · Market data may be delayed.
Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients. Another notable offering is the TearCare System, a wearable eyelid technology employed by ophthalmologists and optometrists for managing dry eye disease (DED). The company makes its products available across the United States, reaching hospitals, medical centers, and eye care professionals through its direct sales force and distribution partners. Founded in 2010, Sight Sciences' corporate operations are based in Menlo Park, California.
Day range
Current $8.14
52-week range
Current $8.14
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
53
Fair Value
Sentiment
50
Mixed
Risk
77
High Risk
Momentum
42
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients. Another notable offering is the TearCare System, a wearable eyelid technology employed by ophthalmologists and optometrists for managing dry eye disease (DED). The company makes its products available across the United States, reaching hospitals, medical centers, and eye care professionals through its direct sales force and distribution partners. Founded in 2010, Sight Sciences' corporate operations are based in Menlo Park, California.
Day range
Current $8.14
52-week range
Current $8.14
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 77.36M USD | 79.87M USD | 81.06M USD | 71.33M USD | 48.96M USD |
| Cost of goods sold | 10.7M USD | 11.58M USD | 11.88M USD | 12.36M USD | 8.61M USD |
| Gross profit | 66.67M USD | 68.29M USD | 69.18M USD | 58.97M USD | 40.35M USD |
| Research and development | 14.61M USD | 17.99M USD | 17.56M USD | 22.86M USD | 15.63M USD |
| Selling, general, and administrative | 89.16M USD | 100.83M USD | 108.89M USD | 120.07M USD | 76.19M USD |
| Operating expenses | 103.77M USD | 118.82M USD | 126.45M USD | 142.92M USD | 91.82M USD |
| Interest income | 3.97M USD | — | — | — | — |
| Interest expense | 5.14M USD | 4.66M USD | 5.41M USD | 4.47M USD | 4.37M USD |
| Depreciation and amortization | 487K USD | 712K USD | 614K USD | 1.25M USD | 1.2M USD |
| Operating income | −37.1M USD | −50.53M USD | −57.27M USD | −83.95M USD | −51.48M USD |
| Net income | −38.43M USD | −51.51M USD | −55.55M USD | −86.24M USD | −62.96M USD |
Company facts updated Sep 12, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$7.00
14.00% downsideFunds reporting this stock among their holdings, ordered by reported position size.
iShares Russell 2000 ETFIWM8.09M0.01%77.55B USD0.19%$288.89+0.41%
Vanguard Morningstar Total Stock Market ETFVTI6.01M0.00%2.3T USD0.03%$376.31+0.82%
iShares Russell 2000 Growth ETFIWO3.02M0.02%14.32B USD0.24%$367.63+0.54%
iShares U.S. Small-Cap Equity Factor ETFSMLF2.28M0.05%4.13B USD0.15%$86.12+0.94%
Vanguard Extended Market ETFVXF2.08M0.00%93.7B USD0.05%$237.76+0.68%
Schwab U.S. Small-Cap ETFSCHA1.31M0.01%22.32B USD0.03%$33.79+0.42%
Vanguard Russell 2000 ETFVTWO1.16M0.01%17.4B USD0.06%$116.76+0.36%
iShares Micro-Cap ETFIWC1.07M0.07%1.44B USD0.60%$190.84+0.39%iShares Russell 2000 ETFIWMVanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 Growth ETFIWOiShares U.S. Small-Cap Equity Factor ETFSMLFVanguard Extended Market ETFVXFSchwab U.S. Small-Cap ETFSCHAVanguard Russell 2000 ETFVTWOiShares Micro-Cap ETFIWCAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
